• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无定形化和球化技术对格列美脲片性能改善的影响

The Impact of Amorphisation and Spheronization Techniques on the Improved & Performance of Glimepiride Tablets.

作者信息

Makar Rana Refaat, Latif Randa, Hosni Ehab Ahmed, El Gazayerly Omaima Naim

机构信息

Faculty of Pharmacy, Ahram Canadian University, Egypt.

Faculty of Pharmacy, Department of Pharmaceutics, Cairo University, Cairo, Egypt.

出版信息

Adv Pharm Bull. 2017 Dec;7(4):557-567. doi: 10.15171/apb.2017.067. Epub 2017 Dec 31.

DOI:10.15171/apb.2017.067
PMID:29399545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5788210/
Abstract

Triple solid dispersion adsorbates (TSDads) and spherical agglomerates (SA) present new techniques that extensively enhance dissolution of poorly soluble drugs. The aim of the present study is to hasten the onset of hypoglycemic effect of glimepiride through enhancing its rate of release from tablet formulation prepared from either technique. Drug release from TSDads or SA tablets with different added excipients was explored. Scanning electron microscopy (SEM) and effect of compression on dissolution were illustrated. Pharmacodynamic evaluation was performed on optimized tablets. TSDads & SA tablets with Cross Povidone showed least disintegration times of 1.48 and 0.5 min. respectively. Kinetics of drug release recorded least half-lives (54.13 and 59.83min for both techniques respectively). Cross section in tablets displayed an organized interconnected matrix under SEM, accounting for the rapid access of dissolution media to the tablet core. Components of tablets filled into capsules showed a similar release profile to that of tablets after compression as indicated by similarity factor. The onset time of maximum reduction in blood glucose in male albino rabbits was hastened to 2h instead of 3h for commercial tablets. After optimization of tablet excipients that interacted differently with respect to their effect on drug release, we could conclude that both amorphisation and spheronization were equally successful in promoting in vitro dissolution enhancement as well as providing a more rapid onset time for drug action in vivo.

摘要

三元固体分散吸附物(TSDads)和球形附聚物(SA)呈现出可广泛提高难溶性药物溶出度的新技术。本研究的目的是通过提高格列美脲从采用这两种技术制备的片剂中的释放速率,来加速其降血糖作用的起效时间。研究了添加不同辅料的TSDads或SA片剂的药物释放情况。阐述了扫描电子显微镜(SEM)以及压片对溶出度的影响。对优化后的片剂进行了药效学评价。含交联聚维酮的TSDads和SA片剂的崩解时间最短,分别为1.48分钟和0.5分钟。药物释放动力学记录的半衰期最短(两种技术分别为54.13分钟和59.83分钟)。片剂的横截面在SEM下显示出有组织的相互连接的基质,这解释了溶出介质能够快速进入片剂核心。填充到胶囊中的片剂成分显示出与压片后片剂相似的释放曲线,相似因子表明了这一点。雄性白化兔血糖最大降幅的起效时间从市售片剂的3小时加快到了2小时。在优化了对药物释放有不同相互作用的片剂辅料后,我们可以得出结论,非晶化和球化在促进体外溶出度提高以及为体内药物作用提供更快起效时间方面同样成功。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/e4836f45f19f/apb-7-557-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/7ab32e3b9861/apb-7-557-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/e8c0cd74241b/apb-7-557-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/c4d01b8482a1/apb-7-557-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/18361ddd3c78/apb-7-557-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/e4836f45f19f/apb-7-557-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/7ab32e3b9861/apb-7-557-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/e8c0cd74241b/apb-7-557-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/c4d01b8482a1/apb-7-557-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/18361ddd3c78/apb-7-557-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45da/5788210/e4836f45f19f/apb-7-557-g005.jpg

相似文献

1
The Impact of Amorphisation and Spheronization Techniques on the Improved & Performance of Glimepiride Tablets.无定形化和球化技术对格列美脲片性能改善的影响
Adv Pharm Bull. 2017 Dec;7(4):557-567. doi: 10.15171/apb.2017.067. Epub 2017 Dec 31.
2
Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.改善格列美脲片的溶解和口服吸收的策略:固体分散体与微粉化技术的比较。
Drug Dev Ind Pharm. 2011 Jun;37(6):727-36. doi: 10.3109/03639045.2010.538061. Epub 2011 Jan 5.
3
Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.氯诺昔康速释微型片的溶出度提高及制剂研究
J Pharm Sci. 2014 Aug;103(8):2470-83. doi: 10.1002/jps.24073. Epub 2014 Jul 3.
4
A New Crystal Engineering Technique for Dissolution Enhancement of Poorly Soluble Drugs Combining Quasi-emulsion and Crystallo-co Agglomeration Methods.一种结合准乳液和结晶共团聚方法提高难溶性药物溶出度的新型晶体工程技术。
Iran J Pharm Res. 2020 Spring;19(2):219-235. doi: 10.22037/ijpr.2020.1101094.
5
Modifying drug release and tablet properties of starch acetate tablets by dry powder agglomeration.通过干粉团聚法改善醋酸淀粉酯片的药物释放及片剂性质。
J Pharm Sci. 2007 Feb;96(2):438-47. doi: 10.1002/jps.20784.
6
Clinical pharmacokinetic study for the effect of glimepiride matrix tablets developed by quality by design concept.基于质量源于设计理念研发的格列美脲骨架片效果的临床药代动力学研究
Drug Dev Ind Pharm. 2018 Jan;44(1):66-81. doi: 10.1080/03639045.2017.1371740. Epub 2017 Sep 11.
7
Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.醋氯芬酸球形团聚体的制备及其体外、临床前和临床研究。
Eur J Pharm Biopharm. 2008 Oct;70(2):674-83. doi: 10.1016/j.ejpb.2008.06.010. Epub 2008 Jun 19.
8
Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.采用液质联用技术制备莪术片剂的研究:体外与体内评价。
Int J Pharm. 2018 Dec 20;553(1-2):157-168. doi: 10.1016/j.ijpharm.2018.10.031. Epub 2018 Oct 11.
9
Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.新型坎地沙坦西酯无定形固体分散体片剂制剂,涉及 P-糖蛋白抑制作用以实现最佳药物递送:体外和体内评价。
Drug Deliv. 2016 Sep;23(7):2124-2138. doi: 10.3109/10717544.2014.945017. Epub 2014 Jul 31.
10
Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.载药介孔硅纳米粒片的处方前研究及其优化:提高疏水性药物水飞蓟宾溶出度的新方法。
Eur J Pharm Sci. 2020 Jan 15;142:105103. doi: 10.1016/j.ejps.2019.105103. Epub 2019 Oct 21.

本文引用的文献

1
The Role of Configurational Entropy in Amorphous Systems.构型熵在非晶态系统中的作用。
Pharmaceutics. 2010 May 25;2(2):224-244. doi: 10.3390/pharmaceutics2020224.
2
Spheronization mechanism of pharmaceutical material crystals processed by extremely high shearing force using a mechanical powder processor.使用机械粉末处理器通过极高剪切力处理的药物原料晶体的球化机制。
Eur J Pharm Biopharm. 2016 Oct;107:7-15. doi: 10.1016/j.ejpb.2016.06.021. Epub 2016 Jun 28.
3
Insoluble drug delivery strategies: review of recent advances and business prospects.
难溶性药物递送策略:近期进展与商业前景综述
Acta Pharm Sin B. 2015 Sep;5(5):442-53. doi: 10.1016/j.apsb.2015.07.003. Epub 2015 Aug 24.
4
Enabling technologies built on a sonochemical platform: challenges and opportunities.基于声化学平台的使能技术:挑战与机遇。
Ultrason Sonochem. 2015 Jul;25:8-16. doi: 10.1016/j.ultsonch.2014.12.004. Epub 2014 Dec 24.
5
The influence of amorphization methods on the apparent solubility and dissolution rate of tadalafil.非晶化方法对他达拉非表观溶解度和溶出速率的影响。
Eur J Pharm Sci. 2014 Oct 1;62:132-40. doi: 10.1016/j.ejps.2014.05.026. Epub 2014 Jun 5.
6
Sonocrystallization and sonofragmentation.声致结晶和超声粉碎。
Ultrason Sonochem. 2014 Nov;21(6):1908-15. doi: 10.1016/j.ultsonch.2014.02.005. Epub 2014 Feb 20.
7
How spherical crystallization improves direct tableting properties: a review.球形结晶如何改善直接压片性能:综述
Adv Pharm Bull. 2012;2(2):253-7. doi: 10.5681/apb.2012.039. Epub 2012 Aug 15.
8
Enhancement of the dissolution of albendazole from pellets using MTR technique.采用 MTR 技术增强阿苯达唑丸的溶出度。
Saudi Pharm J. 2013 Apr;21(2):215-23. doi: 10.1016/j.jsps.2012.03.001. Epub 2012 Mar 19.
9
Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box-Behnken experimental design.通过结晶共附聚法制备和评价附聚晶体:主成分分析和 Box-Behnken 实验设计的综合方法。
Int J Pharm. 2013 Aug 16;452(1-2):135-56. doi: 10.1016/j.ijpharm.2013.04.073. Epub 2013 May 14.
10
Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.改善格列美脲片的溶解和口服吸收的策略:固体分散体与微粉化技术的比较。
Drug Dev Ind Pharm. 2011 Jun;37(6):727-36. doi: 10.3109/03639045.2010.538061. Epub 2011 Jan 5.